NAACCR Item #3920: PSA (Prostatic Specific Antigen) Lab Value
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3920 | 5 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | psaLabValue | Tumor |
Required Status:
NPCR Collect: Required, site specific
CoC Collect: Required, site specific
SEER Collect: Required, site specific
CCCR Collect: Required, site specific; when available
Description
PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer. This data item pertains to PSA lab value.
Rationale
This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 58, _Prostate_. It was previously collected as Prostate, CS SSF# 1.
Allowable Values
0.1, 0.2-999.9, XXX.1, XXX.2, XXX.3, XXX.7, XXX.9
Codes
| Code | Description |
|---|---|
| 0.1 | 0.1 or less nanograms/milliliter (ng/ml) (Exact value to nearest tenth of ng/ml) |
| 0.2-999.9 | 0.2-999.9 ng/ml (Exact value to nearest tenth of ng/ml) |
| XXX.1 | 1,000 ng/ml or greater |
| XXX.2 | Lab value not available, physician states PSA is negative/normal |
| XXX.3 | Lab value not available, physician states PSA is positive/elevated/high |
| XXX.7 | Test ordered, results not in chart |
| XXX.9 | Not documented in medical record PSA lab value not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.